Influence of rheological interventions in peripheral arterial diseases. Pathophysiological and clinical aspects

Issue title: Proceedings of Fifth International Congress of Biorheology. Baden-Baden, F.R. Germany, 20–24 August 1983. Symposium on Hemorheological Disorders in Cardiovascular Diseases

Guest editors: Alfred L. Copley and Siegfried Witte

Article type: Research Article

Authors: Rieger, H.

Affiliations: Aggertalklinik, hospital for vascular diseases, and the department for clinical hemorheology and clinical and experimental angiology, 5250 Engelskirchen and 5100 Aachen, F.R.G.

Abstract: 1.Effects of clinical interest could clearly be demonstrated both by hypofibrinogenization and hemodilution.2.The clinical efficacy of hypofibrinogenization could not been established by clinical trials.3.At the present time there are no studies on hemodilution available.4.The simultaneous application of hypofibrinating enzymes and hemodilution seems to be clinical efficient.5.The true mode of in-vivo action as well as the clinical importance of the so called “hemorheological active drugs” is questionable and unknown respectively.

Keywords: dynamic hematocrit, vasomotoric factors, hypofibrinogenization, hemodilution

DOI: 10.3233/CH-1984-4109

Journal: Clinical Hemorheology and Microcirculation, vol. 4, no. 1, pp. 75-83, 1984